Routine officer departure with consulting bridge — no immediate trading signal. Monitor next filing for the separation agreement to confirm severance terms, but no material impact expected.
Price Chart
Executive Summary
Grace Therapeutics filed an 8-K announcing the departure of Carrie DAndrea as VP of Clinical Operations effective June 5, 2026. She transitioned to a 12-month consulting role at $250/hour with continued stock option vesting. This is a routine officer departure with a pre-arranged consulting transition — no red flags or unexpected C-suite exits.
Key Facts
- Carrie DAndrea ceased as VP of Clinical Operations effective June 5, 2026
- Approved by the Company on June 1, 2026
- Ms. DAndrea entered into a 12-month Consulting Agreement with a fee of $250 per hour
- Stock option awards will continue to vest during the consulting term
- Consulting covers clinical development and NDA-related activities
- Separation agreement not yet executed; will be filed separately
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-024269 |
| Document: ef20075612_8k.htm | 0001140361-26-024269 |
| Document: 0001140361-26-024269-index-headers.html | 0001140361-26-024269 |
| Document: 0001140361-26-024269-index.html | 0001140361-26-024269 |
| Document: 0001140361-26-024269.txt | 0001140361-26-024269 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | Insider Cluster | $2.26 $2.22 | ▼ −1.77% | ▼ −2.62% | $1.93 (−14.60%) |
Aug 13, 2026 10w ago | 8-K | $2.07 $2.16 | ▲ +4.35% | ▲ +4.55% | $1.93 (−6.76%) |
Aug 13, 2026 10w ago | Press Release | $2.07 $2.16 | ▲ +4.35% | ▲ +4.55% | $1.93 (−6.76%) |
Aug 4, 2026 11w ago | Press Release | $2.14 $2.12 | ▼ −0.93% | ▼ −0.77% | $1.93 (−9.81%) |
Jul 28, 2026 12w ago | 8-K | $2.25 $2.08 | ▼ −7.56% | ▼ −6.02% | $1.93 (−14.22%) |
Jun 18, 2026 18w ago | 8-K | $2.38 $2.26 | ▼ −5.04% | ▼ −4.73% | $1.93 (−18.91%) |
Jun 18, 2026 18w ago | 8-K | $2.38 $2.26 | ▲ +5.04% | ▲ +4.73% | $1.93 (+18.91%) |
Jun 18, 2026 18w ago | Press Release | $2.38 $2.26 | ▲ +5.04% | ▲ +4.73% | $1.93 (+18.91%) |
Jun 5, 2026 20w ago | 8-K | $2.30 $2.33 | ▲ +1.30% | ▲ +1.60% | $1.93 (−16.09%) |
Apr 27, 2026 26w ago | 8-K | $2.16 $2.10 | ▲ +2.78% | ▲ +2.29% | $1.93 (+10.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers